Paper3972295
Prognostic factors in carcinoma of the vulva.
Boyce J and 5 others. Gynecol Oncol, 1985. Cited by 100 papers, by iCite.
Cite this record
ConductScience Library. Prognostic factors in carcinoma of the vulva. Papers, record 3972295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3972295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Vulvar Neoplasms | Major topic |
| Clitoris | |
| Female | |
| Groin | |
| Humans | |
| Lymphatic Metastasis | |
| Neoplasm Invasiveness | |
| Prognosis | |
| Vulva |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41514316 | Risk stratification of groin node metastases in vulvar cancer biopsies based on histology and immunohistochemical staining. | J Gynecol Oncol | 2026 | https://conductscience.org/library/papers/41514316 | PubMed |
| 35053582 | Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35053582 | PubMed |
| 33723714 | Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study. | Ann Surg Oncol | 2021 | https://conductscience.org/library/papers/33723714 | PubMed |
| 33293730 | Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense? | Geburtshilfe Frauenheilkd | 2020 | https://conductscience.org/library/papers/33293730 | PubMed |
| 29386916 | Vulvar carcinoma: dilemma, debates, and decisions. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/29386916 | PubMed |
| 24970683 | Sentinel node assessment for diagnosis of groin lymph node involvement in vulval cancer. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/24970683 | PubMed |
| 24672200 | Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study. | J Midlife Health | 2014 | https://conductscience.org/library/papers/24672200 | PubMed |
| 23351240 | Prognostic analysis of early-stage squamous cell carcinoma of the vulva. | World J Surg Oncol | 2013 | https://conductscience.org/library/papers/23351240 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3972295
GET https://conductscience.org/api/papers/v1/3972295/authors